Clinical Trial Update: ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety of liposomal amphotericin B to prevent fungal infections in elderly patients with acute lymphoblastic leukemia has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Fungal Infection

Drugs mentioned

• Liposomal amphotericin B (amphotericin B liposomal)

Snippet

Sponsor: Gilead Sciences | Conditions: Fungal Infection | Phase 4 | Status: TERMINATED